Replies to post #505215 on Anavex Life Sciences Corp (AVXL)

[mike_dotcom]

At BMF Capital, we specialize in forensic short selling.

[boi568]

It reads like a rant because it is a rant. It just reeks of frustration that the company continues to progress against all of their efforts for the past ten years.

I hope they believe their story. It's full of holes, misrepresentations, and smears. I hope they believe it.

[ExtremelyBullishZig]

Brain atrophy has nothing to do with any endpoint being looked at for approval...so it is irrelevant. A2-73 could stop all heart attacks, lover disease, tooth decay, etc., and it wouldn't matter or be relevant as those would all need their own. Trials and 10+ years of BS data too.
What was mentioned was spot on and they come out closer to binary events because that is when there is the most traffic...also the article is centered around EMA approval, so why would it be released any other time?

[attilathehunt]

I wonder why are all these hit pieces are coming out so close to the next CHMP meeting.

Because they want to accumulate on the cheap!